figshare
Browse
IMAGE
b81e41e36ba9a18500e31e53e295e51705d974d8.jpg (122.7 kB)
IMAGE
1ee1b1a63770a7893af64bc0502ee46540cab52f.jpg (108.89 kB)
IMAGE
158c3cd0a41558f8fcf7e085651f8757830ff95b.jpg (134.17 kB)
1/0
3 files

Emergence of polymyxin B-resistant Acinetobacter baumannii in hospitals in Rio de Janeiro

dataset
posted on 2022-06-08, 09:48 authored by Gabrielle L. Genteluci, Daniela B. C. Gomes, Maria José de Souza, Karyne R. Carvalho, Maria Helena S. Villas-Bôas

ABSTRACT Introduction: Acinetobacter baumannii has been considered a prevalent pathogen in hospitals, raising concern in the medical community due to its broad spectrum of antimicrobial resistance. Since it is a subject that arouses much interest, it has been increasingly studied. Due to the emergence of multidrug-resistant (MDR) Gram-negative bacteria, the use of polymyxins was reestablished. The polymyxins have been considered the only option for the treatment of severe infections caused by MDR A. baumannii. Objective: To investigate the susceptibility profile of A. baumannii to polymyxin B. Material and method: 92 clinical isolates from two public hospitals in the Rio de Janeiro city were studied using broth microdilution method. Results: Most of the isolates were resistant to polymyxin B, 81.5% (n = 75), and minimum inhibitory concentration (MIC) values ranged between 4-64 mcg/ml. Conclusion: These results are a concern since currently the polymyxins have been considered the most effective therapeutic option against MDR isolates of A. baumannii.

History

Usage metrics

    Jornal Brasileiro de Pneumologia

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC